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Abstract
Protein interacting with C Kinase 1 (PICK1), a PDZ domain-containing scaffolding protein, interacts with multiple
different proteins in the mammalian nervous system and is believed to play important roles in diverse
physiological and pathological conditions. In this study, we report that PICK1 is expressed in neurons of the dorsal
root ganglion (DRG) and spinal cord dorsal horn, two major pain-related regions. PICK1 was present in
approximately 29.7% of DRG neurons, most of which were small-less than 750 μm
2 in cross-sectional area. Some of
these PICK1-positive cells co-labeled with isolectin B4 or calcitonin-gene-related peptide. In the dorsal horn, PICK1
immunoreactivity was concentrated in the superficial dorsal horn, where it was prominent in the postsynaptic
density, axons, and dendrites. Targeted disruption of PICK1 gene did not affect basal paw withdrawal responses to
acute noxious thermal and mechanical stimuli or locomotor reflex activity, but it completely blocked the induction
of peripheral nerve injury-induced mechanical and thermal pain hypersensitivities. PICK1 appears to be required for
peripheral nerve injury-induced neuropathic pain development and to be a potential biochemical target for
treating this disorder.
Introduction
Neurotransmission requires spatial and functional
assembly of signal transduction machinery at the plasma
membrane. The postsynaptic density, an electron-dense
cytoskeletal structure beneath the plasma membrane of
excitatory synapses, is one site where receptors, chan-
nels, and effectors organize to mediate signaling [1]. The
postsynaptic density contains membrane proteins such
as AMPA receptor (AMPAR) subunits and NMDA
receptor subunits, signal transduction molecules such as
protein kinase C alpha (PKCa) and neuronal nitric
oxide synthase, and scaffolding proteins [1,2]. Most scaf-
folding proteins contain one or more PDZ (PSD-95/Dlg/
ZO-1) amino acid domains [1,3,4]. Through PDZ
domain interaction, they assemble intracellular signaling
complexes around synaptic receptors, regulate synaptic
and non-synaptic receptor trafficking and functions, and
participate in many physiological and pathological pro-
cesses triggered via the activation of synaptic receptors
[1,3-6].
Protein interacting with C Kinase 1 (PICK1), a PDZ
domain-containing scaffolding protein that is enriched
in the postsynaptic density, initially was reported to
interact with PKCa [7] and subsequently was found to
bind to synaptic AMPAR subunit GluR2 in central neu-
rons [8-10]. We recently reported that, via its PDZ
domain, PICK1 interacts with GluR2 and PKCa, recruits
intracellular PKCa to synaptic GluR2, and leads to GluR2
phosphorylation at Ser880 [11-14]. This phosphorylation
disrupts the interaction between synaptic GluR2 and the
anchor protein AMPAR-binding protein/glutamate recep-
tor-interacting protein; promotes synaptic GluR2 internali-
zation; and increases synaptic GluR2-lacking, Ca
2+
permeable AMPARs in dorsal horn neurons [11-14]. In
addition, we have shown previously that preventing dorsal
horn GluR2 internalization through targeted disruption of
PICK1 gene attenuates complete Freund’s adjuvant (CFA)-
induced pain hypersensitivity during the maintenance
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any medium, provided the original work is properly cited.period [14]. These findings suggest that spinal PICK1 may
participate in the maintenance of persistent inflammatory
pain by promoting dorsal horn GluR2 internalization.
However, the expression and distribution of PICK1 in the
pain-related regions of the nervous system have not been
carefully studied. In addition, CFA-induced inflammatory
pain and nerve injury-induced neuropathic pain might
share some intracellular signaling pathways in their central
mechanisms [15], but whether PICK1 is also involved in
the development and maintenance of nerve injury-induced
persistent neuropathic pain is unknown.
In the present study, we first characterized the expres-
sion and distribution of PICK1 in two major pain-
related regions, the dorsal root ganglion (DRG) and
spinal cord dorsal horn. Then, we addressed the role of
PICK1 in neuropathic pain induced by fifth lumbar (L5)
spinal nerve ligation (SNL) and distal transection.
Finally, we examined whether peripheral nerve injury,
like peripheral inflammation, induces dorsal horn GluR2
internalization and whether this induction requires
spinal PICK1 under neuropathic pain conditions.
Materials and methods
Animal preparation
Male mice (10-12 weeks old) and male Sprague-Dawley
rats (225-250 g) were housed on a standard 12-h light/
dark cycle, with water and food pellets available ad libi-
tum. PICK1 knockout (KO) mice (C57BL/6J genetic
background) were generated as described previously
[16]. Male PICK1 KO mice and wild-type (WT) litter-
mates were obtained by interbreeding PICK1 heterozy-
gous mice. To minimize intra- and inter-individual
variability of behavioral outcome measures, animals
were trained for 1-2 days before behavioral testing was
performed. Animal experiments were conducted with
the approval of the Animal Care and Use Committee at
Johns Hopkins University and were consistent with the
ethical guidelines of the National Institutes of Health
and the International Association for the Study of Pain.
All efforts were made to minimize animal suffering and
to reduce the number of animals used. The experimen-
ters were blind to mouse genotype during the behavioral
testing.
Intrathecal administration of PICK1 antisense (AS)
oligodeoxynucleotide (ODN)
To further confirm the results from PICK1 KO mice, we
used a PICK1 AS ODN approach to knock down PICK1
in spinal cord and DRG of rats. Rats were used because
the subarachnoid space of mice is too small to implant
the intrathecal (i.th.) polyethylene (PE-10) catheter that
is required for repeated ODN injections. The design of
PICK1 AS ODN, its control missense (MS) ODN, and
their i.th. administration have been described in our
previous study [14]. Briefly, an i.th. PE-10 catheter was
inserted into the subarachnoid space at the rostral level
of the spinal cord lumbar enlargement segments
through an incision at the atlanto-occipital membrane
[14,17,18]. One week later, rats that showed no neurolo-
gical deficits received an i.th. injection of saline (10 μl;
control), AS ODN (10 μg/10 μl), or MS ODN (10 μg/10
μl) once daily for 4 days. On the second day after ODN
injection, an L5 SNL model of neuropathic pain or sham
surgery was performed as described below.
Neuropathic pain model
An L5 SNL model of neuropathic pain was produced in
mice and rats according to the method described pre-
viously [6,18,19]. In brief, animals were anesthetized
with isoflurane, and a dorsolateral skin incision was
made on the lower back. The sixth lumbar transverse
process was identified and freed of its muscle attach-
ment and then removed. The underlying fifth lumbar
nerve root was isolated, ligated with a silk suture (6-0 in
mice; 3-0 in rats), and transected just distal to the liga-
ture. After appropriate hemostasis, the skin and muscle
layers were closed with a silk suture. In the sham group,
the surgical procedure was identical to that described
above, except that the spinal nerve was not ligated or
transected. Paw withdrawal responses to thermal and
mechanical stimuli on the ipsilateral and contralateral
sides were examined 1 day before and then at various
time point after SNL or sham surgery as described
below.
Behavioral testing
Tail-flick assay: The mouse (5 WT and 5 KO mice) was
placed in a Plexiglas cylinder. A tail-flick apparatus
(Model 33B Tail Flick Analgesia Meter, IITC Life
Science, Woodland Hills, CA, USA) with a radiant heat
source connected to an automatic timer was used to
assess the analgesic response. A cut-off time latency of
10 sec was used to avoid tissue damage to the tail. Tail-
flick latencies were measured as the time required to
induce a tail flick after applying radiant heat to the skin
of the tail. Each trial was repeated five times at 5-min
intervals.
Paw withdrawal responses to noxious thermal stimuli:
The mouse (10 WT and 10 KO mice) or rat (15 rats)
was placed in a Plexiglas chamber on a glass plate above
al i g h tb o x .R a d i a n th e a tf r o mM o d e l3 3 6A n a l g e s i a
Meter (IITC Life Science) was applied by aiming a beam
of light through a hole in the light box through the
glass plate to the middle of the plantar surface of each
hind paw. When the animal lifted its foot, the light
beam automatically shut off. The length of time between
the start of the light beam and the foot lift was defined
as the paw withdrawal latency. Each trial was repeated
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time of 20 sec was used to avoid tissue damage to the
hind paw.
Paw withdrawal responses to repeated mechanical sti-
muli: The mouse (10 WT and 10 KO mice) or rat (15
rats) was placed in a Plexiglas chamber on an elevated
mesh screen. In mice, two calibrated von Frey monofila-
ments (0.24 and 4.33 mN; Stoelting Co., Wood Dale, IL,
USA) were employed. Each von Frey filament was
applied to the hind paw for approximately 1 sec, and
each trial was repeated 10 times to both hind paws. In
rats, a single trial of mechanical stimuli consisted of
eight applications of a calibrated von Frey filament (8.01
mN) within a 2-3-sec period. Each trial was repeated
10 times at 3-min intervals on each hind paw. The
occurrence of paw withdrawal in each of these 10 trials
was expressed as a percent response frequency [(number
of paw withdrawals/10 trials) × 100 = % response fre-
quency], and this percentage was used as an indication
of the amount of paw withdrawal.
Locomotor function testing
The following tests were performed with the experimen-
ter blind to the mouse genotype (5 WT and 5 KO
mice): (1) Placing reflex: the experimenter held the ani-
mal’s hind limbs slightly lower than the forelimbs and
brought the dorsal surfaces of the hind paws into con-
tact with the edge of a table. The experimenter recorded
whether the hind paws were placed on the table surface
reflexively. (2) Grasping reflex: the experimenter placed
the animal on a wire grid and recorded whether the
hind paws grasped the wire on contact. (3) Righting
reflex: the experimenter placed the animal’sb a c ko na
flat surface and noted whether it immediately assumed
the normal upright position. Scores for placing, grasp-
ing, and righting reflexes were based on counts of each
normal reflex exhibited in five trials. In addition, the
animal’s general behaviors, including spontaneous activ-
ity, were observed.
Immunohistochemistry
T h em i c e( 6W Ta n d1K Om o u s e )w e r ed e e p l y
anesthetized with isoflurane and perfused with 4% paraf-
ormaldehyde in phosphate buffer (0.1 M, pH 7.4). The
L4-5 spinal cord segments and DRGs were harvested,
post-fixed in the same fixative solution for 2-4 h, and
cryoprotected by immersion in 30% sucrose overnight at
4°C. The transverse sections (20 μm) were cut on a
cryostat, and four sets of sections from WT mice were
collected. PICK1 immunohistochemical staining alone
was performed on the first set of sections. Briefly, the
sections were blocked for 1 h at 37°C in 0.01 M phos-
phate-buffered saline (PBS) containing 10% normal goat
serum plus 0.3% Triton X-100. The sections were
incubated in primary rabbit antibody for PICK1 (1:500)
[14] for 48 h at 4°C. The specificity and selectivity of
this antibody were reported previously [16]. The sec-
tions were finally incubated in biotinylated goat anti-
rabbit IgG (1:200; Vector Laboratories, Burlingame, CA)
f o r1ha t3 7 ° Cf o l l o w e db ya v i d i n - b i o t i n - p e r o x i d a s e
complex (1:100; Vector) for 1 h at 37°C. The immune
reaction product was visualized by catalysis of 3,3-diami-
nobenzidine by horseradish peroxidase in the presence
of 0.01% H2O2.
Double-immunofluorescence histochemistry for
PICK1/calcitonin gene-related peptide (CGRP) and for
PICK1/NeuN was performed on the second and third
sets of sections, respectively. Briefly, the sections were
incubated sequentially with a mixture of rabbit polyclo-
nal anti-PICK1 (1:500) and mouse monoclonal antibody
to CGRP (1:200; Sigma, St. Louis, MO) or mouse mono-
clonal anti-NeuN (1:600; Chemicon, Temecula, CA)
overnight at 4°C and a mixture of goat anti-rabbit IgG
conjugated with Cy3 and donkey anti-mouse IgG conju-
gated with Cy2 (1:200; Jackson ImmunoResearch, West
Grove, PA) for 1 h at room temperature. Double-fluor-
escence histochemistry for PICK1/biotinylated isolec-
tin (IB)4 was performed on the fourth set of sections.
Briefly, the sections were incubated sequentially with
a mixture of IB4 (1:100; Sigma) and rabbit polyclonal
anti-PICK1 (1:500) overnight at 4°C and a mixture of
goat anti-rabbit IgG conjugated with Cy3 and Cy2-
labeled avidin (1:200, Sigma) for 1 h at room tem-
perature. In control double-labeling experiments,
either of the primary antibodies was omitted or
replaced with normal IgG or serum. All immunofluor-
escence-labeled sections were rinsed in 0.01 M PBS
and mounted onto gelatin-coated glass slides. Cover
slips were applied with a mixture of 50% glycerin and
2.5% triethylene diamine in 0.01 M PBS. The sections
from double-labeling experiments were further
observed with a confocal laser-scanning microscope
by using laser excitation lines of 443-488 nm with
appropriate emission filter for Cy3 (550-570 nm) or
for Cy2 (492-510 nm).
For size distribution analysis of PICK1-positive cells
within the L5 DRG, two sections were randomly selected
from the first set of sections of each animal. All labeled
and unlabeled cells with nuclei were counted. Cell pro-
files were outlined and cell area was calculated with the
imaging software Image-Pro Plus (Media Cybernetics,
Silver Spring, MD). For the analysis of PICK1/CGRP and
PICK1/IB4 double-labeling within the L5 DRG, two sec-
tions each were randomly selected from the second,
third, and fourth set of sections of each animal. Images
were captured directly off the confocal laser-scanning
microscope at 20 × objective magnification. Single-
labeled (PICK1, CGRP, NeuN, or IB4) and double-labeled
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were counted, respectively.
Post-embedding immunogold labeling and electron
microscopy
Post-embedding immunogold labeling was carried out as
described previously [6,12]. Briefly, WT mice (n = 2)
were perfused transcardially with 4% paraformaldehyde +
0.5% glutaraldehyde. Cryoprotected sections from the L5
superficial dorsal horns were frozen in Leica CPC and
freeze-substituted into Lowicryl HM-20 in a Leica AFS
freeze substitution instrument. Ultrathin sections were
labeled with polyclonal rabbit antibody for PICK1. Con-
trols for specificity and selectivity of these antibodies
were performed as described previously [16,20]. Areas for
study were selected at random from the superficial dorsal
horn at low magnification (i.e., synapses not visible) and
then micrographs of synapses were taken at high
magnification.
Subcellular fractionation of proteins
Biochemical fractionation was carried out according to
previous studies with minor modification [6,12,19]. The
mice (10 WT and 10 KO mice/time point) were sacri-
ficed by decapitation, and the tissues from L4 and L5
segments were dissected. The ipsilateral spinal cord was
separated from the contralateral spinal cord under a
surgical microscope and collected. Ipsilateral L4 or L5
spinal cords from two mice were pooled together and
homogenized in homogenization buffer (50 mM Tris-
H C l ,0 . 1m ME D T A ,0 . 1m ME G T A ,1m Mp h e n y -
methylsulfonyl fluoride, 1 μM leupeptin, 2 μM pepstain
A). After the homogenate was centrifuged at 1,000 × g
for 20 min at 4°C, the supernatant (S1, total soluble
fraction) was collected and the pellet (P1, nuclei and
debris fraction) discarded. The supernatant was centri-
fuged at 10,000 × g for 20 min to produce a pellet (P2)
and supernatant (S2). The P2 was lysed hypo-osmoti-
cally in water and centrifuged at 25,000 × g to produce
a final pellet (P3). The S2 was considered to be the
crude cytosolic fraction and the P3 the crude synaptoso-
mal membrane fraction.
Western blotting analysis
After protein concentration was measured, proteins (30
μg) were heated for 5 min at 98°C and loaded onto 4%
stacking/7.5% separating SDS-polyacrylamide gels for
protein separation. The protein was then electrophoreti-
cally transferred onto a nitrocellulose membrane. The
membrane was blocked with 3% nonfat dry milk and
subsequently incubated for 1 h with polyclonal rabbit
primary antibody for PICK1 (1:1,000), GluR2 (1:500;
Upstate/CHEMICON, Temecula, CA), PKCa (1:1,000;
S a n t aC r u zB i o t e c h n o l o g y ,S a n t aC r u z ,C A ) ,a c i d -
sensing ion channel (ASIC) 1 (1:1000; Santa Cruz),
ASIC2 (1:1000; Santa Cruz), or N-cadherin (1:1,000; BD
Biosciences, Palo Alto, CA), and monoclonal mouse pri-
mary antibody for b-actin (1:3,000; Santa Cruz Biotech-
nology). The proteins were detected by horseradish
peroxidase-conjugated anti-rabbit or anti-mouse second-
ary antibodies and visualized with chemiluminescence
reagents provided with the ECL kit (Amersham Pharma-
cia Biotech, Piscataway, NJ) and exposure to film. The
intensity of blots was quantified with densitometry. The
blot density from naïve animals was set as 100%.
Statistical Analysis
The results from the behavioral tests, Western blotting,
and immunohistochemistry were analyzed statistically
with a one-way or two-way analysis of variance
(ANOVA). Data are presented as means ± SEM. When
ANOVA showed significant difference, pairwise compar-
isons between means were tested by the post hoc Tukey
method. Significance was set at P < 0.05. The statistical
software package SigmaStat (Systat, San Jose, CA) was
used to perform all statistical analyses.
Results
PICK1-positive cells were observed in the DRG of WT
mice, but not of PICK1 KO mice (Figure 1A). Most
were small, ranging from 250 to 750 μm
2 in surface area
(Figure 1B). Some medium-size DRG cells were also
PICK1-positive (Figure 1B). In contrast to small DRG
cells, the population of large-diameter DRG cells mostly
lacked PICK1. Approximately 29.7% of the 1124 DRG
cells counted were PICK1-positive. Double-labeling stu-
dies showed that PICK1 was colocalized exclusively with
NeuN, a marker for neuronal nuclei [21], but was absent
from glia (Figure 2A). We further identified the cyto-
chemical characteristics of PICK1-positive neurons in
the DRG. Approximately 62.8% (211/336) of PICK1-
positive neurons were positive for IB4, a marker for
small DRG non-peptidergic neurons [21], and approxi-
mately 26.9% (125/465) of PICK1-positive neurons were
positive for CGRP, a marker for small DRG peptidergic
neurons [21].
PICK1 protein was also observed in the spinal cord.
PICK1 immunoreactivity was distributed at a higher
density in the superficial dorsal horn than in other
regions of spinal cord, particularly in the lamina I and
inner lamina II (Figure 3A). Under high magnification,
immunoreactivity to PICK1 was observed mostly as
punctate or patch immunostaining (Figure 3B). A few
PICK1-positive cell bodies were seen in dorsal horn
(Figure 3B). Under electron microcopy, immunogold-
labeling for PICK1 was prominent in the postsynaptic
density, dendrites, and presynaptic terminals in the
superficial dorsal horn (Figure 3C and 3D).
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whether PICK1 participated in transmission and modu-
lation of nociceptive information. Because PICK1 is a
scaffolding protein without any receptor-like or enzyme-
like activities, we used a genomic strategy in which the
PICK1 gene was mutated. As reported previously [16],
PICK1 KO male and female mice are viable with normal
appearance. The genomic status of each mouse was
checked with PCR (Figure 4A), and the expression of
PICK1 protein in the DRG and spinal cord also was ver-
ified by Western blotting analysis and immunohisto-
chemistry. As expected, PICK1 was not detected in the
DRG or spinal cord of the PICK1 KO mice (Figures 1A
and 4B). In addition, the expression of PICK1 interact-
ing proteins was evaluated in the DRG and spinal cord.
Western blotting analysis revealed that the levels of
interacting proteins ASIC1 and ASIC2 in the DRG (Fig-
ure 4B) and the levels of interacting proteins GluR2 and
PKCa in the spinal cord (Figure 4C) were normal in the
PICK1 KO mice. The DRG and spinal cord cell
architecture appeared normal in PICK1 KO mice (data
not shown). These results suggest that the targeted dis-
ruption of PICK1 gene does not produce any detectable
abnormality of DRG or spinal cord anatomical structure
or protein expression except for the loss of PICK1
protein.
We first examined whether the deletion of PICK1
affected acute nociception. Acute mechanical sensitivity
was assessed by response frequencies of paw withdrawal
to mechanical stimulation elicited by different forces of
von Frey filaments. Acute thermal sensitivity was evalu-
ated by high-intensity radiant heat applied to the plantar
sides of left and right hind paws and the tail. We found
that paw withdrawal responses of PICK1 KO mice to
acute mechanical (Figure 5A) and thermal stimuli
(Figure 5B) as well as tail flick response to acute thermal
stimulation (Figure 5C) were similar to those of WT
mice. These data indicate that transmission of acute
pain messages is preserved in PICK1 KO mice.
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Figure 1 Localization and distribution of PICK1 immunoreactivity
in the dorsal root ganglion (DRG). A, Distribution of PICK1
immunoreactivity in the DRG cells of wild-type (WT; left) and PICK1
knockout (KO, right) mice. No immunoreactivity for PICK1 was
observed in the DRG of PICK1 KO mice. Scale bar: 200 μm. B,
Histogram showing the frequency of PICK1-positive and -negative
somata in the DRG of WT mice by cross-sectional area.
A
PICK1 Merged NeuN
B
PICK1 IB4 Merged
C C
PICK1 CGRP Merged
Figure 2 PICK1 immunoreactivity in the DRG neurons and
colocalization with IB4 binding and CGRP. Digital images were
taken with a confocal laser-scanning microscope. A, Colocalization
of PICK1 and NeuN. B, Colocalization of PICK1 and IB4 binding.
C, Colocalization of PICK1 and CGRP. Scale bars: 5 μm.
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pain. Consistent with our previous studies [6,22], L5 SNL
produced long-term mechanical and thermal pain hyper-
sensitivity on the hind paw ipsilateral to nerve injury in
WT mice. The application of 0.24 mN (low intensity)
and 4.33 mN (moderate intensity) von Frey filaments to
the plantar side of the ipsilateral hind paw elicited paw
withdrawal frequencies that were significantly greater
than those at pre-injury baseline values. This mechanical
pain hypersensitivity was detectable on day 3, reached a
peak level between days 7 and 9, and persisted for at least
14 days post-nerve injury (Figure 6A and 6B). Likewise,
paw withdrawal latencies in response to application of
heat to the plantar side of the ipsilateral hind paw were
markedly decreased from the pre-injury baseline values.
This thermal pain hypersensitivity developed within
5 days and persisted for at least 14 days (Figure 6C). The
baseline withdrawal responses to mechanical and thermal
stimuli were similar in WT and PICK1 KO mice as
described above (Figure 6), but PICK1 KO mice did not
display mechanical or thermal pain hypersensitivity fol-
lowing spinal nerve injury. Paw withdrawal responses to
mechanical and thermal stimuli were unchanged com-
pared to the baseline levels in the PICK1 KO mice (P >
0.05; Figure 6). As expected, paw withdrawal responses
to mechanical and thermal stimuli were not altered in
the contralateral hind paw in either WT or PICK1 KO
mice after spinal nerve injury (Figure 6).
Because locomotor function is involved in paw with-
drawal reflex response, we tested whether the deletion
of PICK1 affected locomotor functions. We recorded
the scores for three gross reflexes (placing, grasping, and
righting) in WT and PICK1 KO mice. We found that
PICK1 KO mice performed the same as their WT litter-
mates for the three reflexes (Table 1) and did not exhi-
bit gross motor coordination defects. The results
s u g g e s tt h a tg r o s sl o c o m o t o r function is not impaired
by PICK1 deficiency and cannot account for the
observed deficiency of nerve injury-induced pain
behaviors.
PICK1 genetic KO mice, like other congenital KO
mice, might undergo unknown compensatory changes
in the nervous system during development. Such
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C D
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Figure 3 Localization and distribution of PICK1 immunoreactivity
in the spinal cord. A, PICK1 immunoreactivity in the dorsal horn was
strongest in lamina I and inner lamina II (IIi). IIo: outer lamina II. B,H i g h
magnification of the outlined region from A. PICK1-positive somata
(arrows), punctation, and patches (arrow heads) were observed.
C, Immunogold labeling for PICK1 is prominent in the postsynaptic
density (arrow). D, Immunogold labeling for PICK1 is prominent in the
presynaptic terminal (arrows) and postsynaptic dendrite (arrowhead).
Pre: presynaptic. Post: postsynaptic. Scale bars: 100 μmi nA ,5μmi nB ,
100 nm in C and D.
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ȕ-actin
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Figure 4 Biochemical characterization of PICK1 knockout (KO) mice. A, PCR analysis of tail DNA from wild-type (WT), heterozygous (HET),
and PICK1 KO mice. M: molecular weight standard. B, Western blot analysis shows the expression of PICK1 protein and its interacting proteins
ASIC1 and ASIC2 in the DRG from WT and PICK1 KO mice. C, Western blot analysis shows the expression of PICK1 and its interacting proteins
GluR2 and PKCa in the spinal cord from WT and PICK1 KO mice.
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f i r mt h er o l eo fP I C K 1i nn e u r o p a t h i cp a i n ,w eu s e d
PICK1 AS ODN to acutely and transiently knock down
P I C K 1i ns p i n a lc o r da n dD R Go fr a t s .O u rp r e v i o u s
study showed that i.th. administration of PICK1 AS
ODN (10 μg), but not MS ODN (10 μg), selectively and
significantly reduced PICK1 expression in spinal cord
and DRG [14]. This reduction did not affect basal
mechanical and thermal responses or locomotor func-
tion, but it did attenuate CFA-induced mechanical and
thermal pain hypersensitivities [14]. Here, we found that
after i.th. injection of 10 μg PICK1 AS ODN, mechanical
and thermal pain hypersensitivities were markedly
blunted until day 7 post-SNL (Figure 7). Significant dif-
ferences in paw withdrawal frequencies and latencies
were observed between the AS group (n = 5) and saline
group (n = 5; P < 0.01). As expected, 10 μg of MS ODN
did not affect the development of nerve injury-induced
mechanical and thermal pain hypersensitivities (P >
0.05, n = 5; Figure 7).
Results from our previous study suggested that
PICK1-mediated dorsal horn GluR2 internalization con-
tributes to the maintenance of CFA-induced chronic
inflammatory pain. Therefore, we examined whether a
similar process might occur in neuropathic pain. Crude
cytosolic and synaptosomal membrane protein fractions
were separated by using differential centrifugation. Con-
sistent with our previous studies [11,12,19], a plasma
membrane-specific protein, N-cadherin, was detected
highly in the membrane fractions, but not in the cytoso-
lic fraction (data not shown), indicating that the fractio-
nation procedure effectively separated cytosolic proteins
from synaptosomal membrane proteins. We found that
L5 SNL did not change the level of GluR2 in either the
cytosolic or the synaptosomal fraction from the ipsilat-
eral L4 (data not shown) and L5 (Figure 8) dorsal horns
of WT and PICK1 KO mice during the observation per-
iod. These findings indicate that peripheral nerve injury
does not induce GluR2 internalization in dorsal horn.
Discussion
Neuropathic pain is a chronic condition that affects mil-
lions of people worldwide. Current treatments are often
inadequate, ineffective, or produce potentially severe
adverse effects. Therefore, the search for novel therapeu-
tic and preventive strategies is essential. Here, we report
that PICK1, a PDZ domain-containing scaffolding pro-
tein, might be required for the induction of nerve
injury-induced neuropathic pain, suggesting that PICK1
may be a new target for the prevention and/or treat-
ment of this disorder.
The present study demonstrated that PICK1 was
expressed in two major pain-related regions, DRG and
dorsal horn. We found that approximately 30% of DRG
neurons were positive for PICK1 and that most of such
neurons were small. Both peptidergic and non-peptider-
gic neurons were represented. In the dorsal horn,
PICK1-positive terminals, fibers, and cell bodies were
concentrated on the superficial dorsal horn, especially in
lamina I and inner lamina II. Under electron micro-
scopy, immunogold labeling for PICK1 was associated
with the postsynaptic density in the dendrites of the
superficial dorsal horn neurons. In line with this finding,
we previously showed that PICK1 was expressed more
highly in the dorsal horn than in the ventral horn or
DRG [14]. Abundant expression of PICK1 in small DRG
neurons and superficial dorsal horn neurons suggests
that it might participate in transmission and modulation
of nociceptive information.
PICK1 plays distinct roles in acute pain and neuro-
pathic pain. The present study showed intact response to
noxious mechanical and thermal stimuli in naïve PICK1
KO mice, indicating that PICK1 might not be involved in
acute pain transmission. In contrast, PICK1 knockout
abolished nerve injury-induced pain hypersensitivity dur-
ing the development and maintenance periods. More-
over, PICK1 knockdown in spinal cord and DRG
significantly attenuated nerve injury-induced develop-
ment of pain hypersensitivity. These findings suggest that
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Page 7 of 11PICK1 in spinal cord and DRG contributes to neuro-
pathic pain. Our previous study demonstrated that spinal
PICK1 deficiency also attenuated pain hypersensitivity
during the maintenance period of CFA-induced inflam-
matory pain [14]. Moreover, we found that this effect
might be attributable to reduction of NMDA receptor/
PKC-triggered dorsal horn GluR2 internalization in CFA-
induced inflammatory pain maintenance [12-14]. We
expected to observe this mechanism in neuropathic pain
as well. However, we detected no significant change in
the level of GluR2 in cytosolic or synaptosomal
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Figure 6 PICK1 knockout (KO) mice exhibit impaired
neuropathic pain.L 5 SNL significantly increased paw withdrawal
frequencies in response to 0.24 mN (low intensity; A) and 4.33 mN
(moderate intensity; B) mechanical stimuli and significantly
decreased paw withdrawal latency in response to heat stimulation
(C) on the ipsilateral (ipsi), but not contralateral (contra), side in
wild-type (WT) mice. PICK1 KO mice failed to exhibit any changes in
paw withdrawal frequencies or latencies during the observation
period. * P < 0.05, ** P < 0.01 vs the corresponding time points in
PICK1 KO mice on the ipsilateral side.
Table 1 Mean (SEM) changes in locomotor test
Placing Grasping Righting
WT 5 (0) 5 (0) 5 (0)
PICK1 KO 5 (0) 5 (0) 5 (0)
N = 5, 5 trials.
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both mechanical and thermal pain hypersensitivities on days 3 and
5 post-SNL. No significant differences in paw withdrawal frequencies
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those treated with missense (MS) ODN (10 μg). ** P < 0.01 vs the
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Page 8 of 11membrane fractions from dorsal horn of WT or PICK1
KO mice after L5 SNL. These results indicate that
SNL-induced nerve injury input, unlike CFA-induced
inflammatory input, does not promote dorsal horn GluR2
internalization. Hence, PICK1 may participate in neuro-
pathic pain development via other potential mechanisms,
even as it binds to its partners PKCa and GluR2.
In addition to interacting with GluR2, PICK1 interacts
specifically with the C-termini of ASIC1 and ASIC2 in
central neurons via its PDZ domain [23,24]. ASIC1 is
expressed predominantly in small-diameter DRG
neurons, whereas ASIC2 is localized to the plasma
membrane of small-, medium-, and large-diameter cells
of the DRG [25-27]. Disrupting the mouse ASIC2 gene
markedly reduces the sensitivity of a specific component
of mechanosensation [28]. Moreover, PICK1 potentiates
PKA phosphorylation of ASIC1 and increases ASIC2
current by enhancing its phosphorylation by PKC [29].
It seems that the anti-hyperalgesic effect caused by
PICK1 deficiency in neuropathic pain might be due to a
reduction in function of DRG ASIC1 and ASIC2.
PICK1’s PDZ domain also binds to metabotropic gluta-
mate receptor subunit 7 (mGluR7) in central neurons. An
inhibitory presynaptic receptor, mGluR7 is expressed in
the DRG neurons and primary afferent terminals [30,31].
It is activated under neuropathic pain conditions, but not
under normal conditions [32-34]. Because PICK1 inhibits
PKC phosphorylation of mGluR7 [9,35,36], it is possible
that PICK1 deficiency causes a loss of inhibition of
mGluR7 phosphorylation and potentiates mGluR7 activa-
tion. Activated mGluR7 would then inhibit glutamate
release from primary afferents and result in an antinoci-
ceptive effect in neuropathic pain. The possibility that
DRG PICK1 might contribute to neuropathic pain by reg-
ulating ASIC1, ASIC2, and mGluR7 functions remains to
be further confirmed. It is noteworthy that during neuro-
pathic pain PICK1 still interacts with other proteins, such
as Eph receptor tyrosine kinase [37], dopamine transporter
[38], and class I ADP-ribosylation factors [39]. Whether
these interactions are involved in neuropathic pain is
unknown.
In summary, we showed that PICK1 was expressed in
the DRG and superficial dorsal horn neurons. Behavioral
studies demonstrated that knockout of PICK1 abolished
pain hypersensitivity during nerve injury-induced neuro-
pathic pain development and maintenance, without
affecting acute pain or locomotor function. Although the
mechanism of this antinociceptive effect in neuropathic
pain is still unclear, PICK1 appears to be a potential tar-
get for prevention and/or treatment of this disorder.
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Figure 8 L5 spinal nerve ligation (SNL) does not induce GluR2 internalization in dorsal horns from wild-type (WT) mice. A, GluR2 levels
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